Unicycive Therapeutics, Inc. ( UNCY) - Stock Earnings
UNCY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -6.0 million USD | — USD |
| 2025Q4 | -14.7 million USD | — USD |
| 2026Q1 | -12.8 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
UNCY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.5 million USD | 675000 USD |
| 2024 | -36.7 million USD | — USD |
| 2025 | -26.6 million USD | — USD |
| 2026 Est. | — | — |
UNCY
Price: $7.17
52 week price:
Earnings Per Share: -2.25 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 23619
Market Capitalization: 148.7 million